{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T02:07:01Z","timestamp":1783476421575,"version":"3.55.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,5]],"date-time":"2024-04-05T00:00:00Z","timestamp":1712275200000},"content-version":"am","delay-in-days":370,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007179","name":"University of New Mexico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007179","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017215","name":"University of New Mexico Health Sciences Center","doi-asserted-by":"publisher","award":["UL1TR001449"],"award-info":[{"award-number":["UL1TR001449"]}],"id":[{"id":"10.13039\/100017215","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.eprac.2022.12.007","type":"journal-article","created":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T11:04:30Z","timestamp":1671275070000},"page":"229-234","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Risk Assessment and Coronary Artery Calcium Scoring in Transgender and Gender-Diverse Individuals Receiving Gender-Affirming Hormone Therapy"],"prefix":"10.1016","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4559-1022","authenticated-orcid":false,"given":"Teodor","family":"Duro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Molly","family":"McClain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelsea Gallegos","family":"Aragon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Casson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun Ho Eunice","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Bouchonville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Kapsner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"suppl 1","key":"10.1016\/j.eprac.2022.12.007_bib1","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1080\/26895269.2022.2100644","article-title":"Standards of care for the health of transgender and gender diverse people, version 8","volume":"23","author":"Coleman","year":"2022","journal-title":"Int J Transgender Health"},{"issue":"4","key":"10.1016\/j.eprac.2022.12.007_bib2","doi-asserted-by":"crossref","first-page":"256","DOI":"10.7326\/M17-0577","article-title":"Cardiovascular disease among transgender adults receiving hormone therapy: a narrative review","volume":"167","author":"Streed","year":"2017","journal-title":"Ann Intern Med"},{"issue":"8","key":"10.1016\/j.eprac.2022.12.007_bib3","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.amjmed.2021.02.031","article-title":"Assessment of cardiovascular risk in transgender patients presenting for gender-affirming care","volume":"134","author":"Denby","year":"2021","journal-title":"Am J Med"},{"issue":"4","key":"10.1016\/j.eprac.2022.12.007_bib4","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1210\/js.2017-00465","article-title":"Health and cardiometabolic disease in transgender adults in the United States: behavioral risk factor surveillance system 2015","volume":"2","author":"Nokoff","year":"2018","journal-title":"J\u00a0Endocr Soc"},{"issue":"6","key":"10.1016\/j.eprac.2022.12.007_bib6","doi-asserted-by":"crossref","first-page":"e136","DOI":"10.1161\/CIR.0000000000001003","article-title":"Assessing and addressing cardiovascular health in people who are transgender and gender diverse: a scientific statement from the American Heart Association","volume":"144","author":"Streed","year":"2021","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.eprac.2022.12.007_bib7","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.119.005597","article-title":"Cardiovascular disease risk factors and myocardial infarction in the transgender population","volume":"12","author":"Alzahrani","year":"2019","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"17","key":"10.1016\/j.eprac.2022.12.007_bib8","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1056\/NEJM199110243251702","article-title":"Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins","volume":"325","author":"Walsh","year":"1991","journal-title":"N\u00a0Engl J Med"},{"issue":"9 Pt 1","key":"10.1016\/j.eprac.2022.12.007_bib9","doi-asserted-by":"crossref","first-page":"754","DOI":"10.7326\/0003-4819-134-9_Part_1-200105010-00012","article-title":"Effects of hormone replacement therapy on serum lipids in elderly women. a randomized, placebo-controlled trial","volume":"134","author":"Binder","year":"2001","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.eprac.2022.12.007_bib10","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1196\/annals.1365.031","article-title":"Hormone replacement therapy and cardioprotection: what is good and what is bad for the cardiovascular system?","volume":"1092","author":"Rosano","year":"2006","journal-title":"Ann N Y Acad Sci"},{"issue":"4","key":"10.1016\/j.eprac.2022.12.007_bib11","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1160\/TH06-10-0567","article-title":"Haemostatic activation in post-menopausal women taking low-dose hormone therapy: less effect with transdermal administration?","volume":"97","author":"Brosnan","year":"2007","journal-title":"Thromb Haemost"},{"issue":"2","key":"10.1016\/j.eprac.2022.12.007_bib12","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.atherosclerosis.2005.12.030","article-title":"Different effects of oral conjugated estrogen and transdermal estradiol on arterial stiffness and vascular inflammatory markers in postmenopausal women","volume":"189","author":"Sumino","year":"2006","journal-title":"Atherosclerosis"},{"issue":"2","key":"10.1016\/j.eprac.2022.12.007_bib13","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/cen.13050","article-title":"Cyproterone acetate vs leuprolide acetate in combination with transdermal oestradiol in transwomen: a comparison of safety and effectiveness","volume":"85","author":"Gava","year":"2016","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"10.1016\/j.eprac.2022.12.007_bib14","doi-asserted-by":"crossref","first-page":"429","DOI":"10.7326\/0003-4819-118-6-199303150-00006","article-title":"Influence of sex hormones on plasma endothelin levels","volume":"118","author":"Polderman","year":"1993","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.eprac.2022.12.007_bib15","doi-asserted-by":"crossref","first-page":"582","DOI":"10.2105\/AJPH.2016.303648","article-title":"Demographic Characteristics and health status of transgender adults in select US regions: behavioral risk factor surveillance system, 2014","volume":"107","author":"Meyer","year":"2017","journal-title":"Am J Public Health"},{"issue":"4","key":"10.1016\/j.eprac.2022.12.007_bib16","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1530\/EJE-10-1038","article-title":"A\u00a0long-term follow-up study of mortality in transsexuals receiving treatment with cross-sex hormones","volume":"164","author":"Asscheman","year":"2011","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"10.1016\/j.eprac.2022.12.007_bib17","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1530\/EJE-13-0493","article-title":"Prevalence of cardiovascular disease and cancer during cross-sex hormone therapy in a large cohort of trans persons: a case-control study","volume":"169","author":"Wierckx","year":"2013","journal-title":"Eur J Endocrinol"},{"issue":"11","key":"10.1016\/j.eprac.2022.12.007_bib18","doi-asserted-by":"crossref","first-page":"3914","DOI":"10.1210\/jc.2017-01643","article-title":"Sex steroids and cardiovascular outcomes in transgender individuals: a systematic review and meta-analysis","volume":"102","author":"Maraka","year":"2017","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.eprac.2022.12.007_bib19","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1530\/EJE-14-0011","article-title":"Cardiovascular disease in transsexual persons treated with cross-sex hormones: reversal of the traditional sex difference in cardiovascular disease pattern","volume":"170","author":"Gooren","year":"2014","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"10.1016\/j.eprac.2022.12.007_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpcardiol.2018.09.003","article-title":"Gender identity, hormone therapy, and cardiovascular disease risk","volume":"45","author":"Martinez","year":"2020","journal-title":"Curr Probl Cardiol"},{"key":"10.1016\/j.eprac.2022.12.007_bib21","first-page":"209","article-title":"Managing the risk of venous thromboembolism in transgender adults undergoing hormone therapy","volume":"10","author":"Goldstein","year":"2019","journal-title":"J\u00a0Blood Med"},{"issue":"10","key":"10.1016\/j.eprac.2022.12.007_bib22","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/j.cjco.2021.05.007","article-title":"The effect of testosterone on cardiovascular disease and cardiovascular risk factors in men: a review of clinical and preclinical data","volume":"3","author":"Kaur","year":"2021","journal-title":"CJC Open"},{"issue":"2","key":"10.1016\/j.eprac.2022.12.007_bib23","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1056\/NEJMoa1000485","article-title":"Adverse events associated with testosterone administration","volume":"363","author":"Basaria","year":"2010","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1016\/j.eprac.2022.12.007_bib24","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1001\/jama.2016.21043","article-title":"Testosterone treatment and coronary artery plaque volume in older men with low testosterone","volume":"317","author":"Budoff","year":"2017","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.eprac.2022.12.007_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0085805","article-title":"Increased risk of non-fatal myocardial infarction following testosterone therapy prescription in men","volume":"9","author":"Finkle","year":"2014","journal-title":"PLoS One"},{"issue":"17","key":"10.1016\/j.eprac.2022.12.007_bib26","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1001\/jama.2013.280386","article-title":"Association of testosterone therapy with mortality, myocardial infarction, and stroke in men with low testosterone levels","volume":"310","author":"Vigen","year":"2013","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.eprac.2022.12.007_bib27","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1001\/jamainternmed.2016.9546","article-title":"Association of testosterone replacement with cardiovascular outcomes among men with androgen deficiency","volume":"177","author":"Cheetham","year":"2017","journal-title":"JAMA Intern Med"},{"issue":"3","key":"10.1016\/j.eprac.2022.12.007_bib28","doi-asserted-by":"crossref","first-page":"R25","DOI":"10.1530\/JOE-12-0455","article-title":"Testosterone: a metabolic hormone in health and disease","volume":"217","author":"Kelly","year":"2013","journal-title":"J\u00a0Endocrinol"},{"issue":"4","key":"10.1016\/j.eprac.2022.12.007_bib29","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0002-9343(01)00833-6","article-title":"Intramuscular testosterone esters and plasma lipids in hypogonadal men: a meta-analysis","volume":"111","author":"Whitsel","year":"2001","journal-title":"Am J Med"},{"issue":"8","key":"10.1016\/j.eprac.2022.12.007_bib30","article-title":"Testosterone replacement therapy in hypogonadal men and myocardial infarction risk: systematic review & meta-analysis","volume":"13","author":"Lee","year":"2021","journal-title":"Cureus"},{"issue":"7","key":"10.1016\/j.eprac.2022.12.007_bib31","doi-asserted-by":"crossref","first-page":"3989","DOI":"10.1210\/jc.2005-0553","article-title":"Independent and combined effects of testosterone and growth hormone on extracellular water in hypopituitary men","volume":"90","author":"Johannsson","year":"2005","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.eprac.2022.12.007_bib32","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/qjmed\/hci054","article-title":"Castration reduces platelet thromboxane A2 receptor density and aggregability","volume":"98","author":"Ajayi","year":"2005","journal-title":"QJM"},{"issue":"5","key":"10.1016\/j.eprac.2022.12.007_bib33","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1111\/andr.12382","article-title":"Effects of testosterone therapy on BMI, blood pressure, and laboratory profile of transgender men: a systematic review","volume":"5","author":"Velho","year":"2017","journal-title":"Andrology"},{"issue":"1","key":"10.1016\/j.eprac.2022.12.007_bib34","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.mayocp.2017.11.006","article-title":"Testosterone and cardiovascular health","volume":"93","author":"Elagizi","year":"2018","journal-title":"Mayo Clin Proc"},{"issue":"1","key":"10.1016\/j.eprac.2022.12.007_bib35","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.atherosclerosis.2009.01.007","article-title":"Cigarette smoking: an undertreated risk factor for cardiovascular disease","volume":"205","author":"Erhardt","year":"2009","journal-title":"Atherosclerosis"},{"issue":"4","key":"10.1016\/j.eprac.2022.12.007_bib36","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/0735-1097(90)90282-T","article-title":"Quantification of coronary artery calcium using ultrafast computed tomography","volume":"15","author":"Agatston","year":"1990","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.eprac.2022.12.007_bib37","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1001\/jamacardio.2016.5493","article-title":"Association of coronary artery calcium in adults aged 32 to 46 years with incident coronary heart disease and death","volume":"2","author":"Carr","year":"2017","journal-title":"JAMA Cardiol"},{"issue":"6","key":"10.1016\/j.eprac.2022.12.007_bib38","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1161\/CIRCULATIONAHA.107.699579","article-title":"General cardiovascular risk profile for use in primary care: the Framingham Heart Study","volume":"117","author":"D\u2019Agostino","year":"2008","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.eprac.2022.12.007_bib39","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.jcmg.2012.01.022","article-title":"Yield of screening for coronary artery calcium in early middle-age adults based on the 10-year Framingham Risk Score: the CARDIA study","volume":"5","author":"Okwuosa","year":"2012","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.eprac.2022.12.007_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajpc.2021.100223","article-title":"Characteristics of transgender women referred to women\u2019s heart clinic","volume":"7","author":"Mahowald","year":"2021","journal-title":"Am J Prev Cardiol"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X22008977?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X22008977?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:14:10Z","timestamp":1761516850000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X22008977"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S1530891X22008977"],"URL":"https:\/\/doi.org\/10.1016\/j.eprac.2022.12.007","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk Assessment and Coronary Artery Calcium Scoring in Transgender and Gender-Diverse Individuals Receiving Gender-Affirming Hormone Therapy","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eprac.2022.12.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 AACE. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}